The Latest Cardiac and Vascular News
Data Published in JACC: Clinical Electrophysiology and to be Presented at American Heart Association Scientific Sessions Demonstrates the Potential of Investigational Algorithms in Medtronic Micra Pacemaker to Improve Synchrony and Cardiac Function in AV Block Patients DUBLIN, Nov. 11, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced results from the MARVEL […]
ST. LOUIS and MT. OLIVE, N.J., Nov. 08, 2019 (GLOBE NEWSWIRE) — Stereotaxis (NYSE American: STXS) and Catheter Precision today announced the first patients have been successfully treated with the integration of Catheter Precision’s VIVO™ arrhythmia localization and Stereotaxis’ Robotic Magnetic Navigation technologies. VIVO uses information commonly collected prior to cardiac procedures to identify […]
ST. LOUIS and PESSAC, France, Nov. 05, 2019 (GLOBE NEWSWIRE) — Stereotaxis (NYSE American: STXS) and inHEART today announced the first patients have been successfully treated with the integration of inHEART’s advanced preoperative mapping and Stereotaxis’ Robotic Magnetic Navigation technologies. inHEART applies advanced algorithms on preoperative CT and MRI images to generate highly detailed […]
NEW YORK–(BUSINESS WIRE)–Ninety One, Inc., an Augmented Intelligence company developing an innovative software and data science platform designed to automate Cardiac Remote Monitoring and further Precision Medicine, announced today that Dr. Andrea Natale, M.D., F.A.C.C., F.H.R.S., F.E.S.C., Executive Medical Director of Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, has been […]
2020 Payment Rules from the Centers for Medicare and Medicaid Services Bring CCM Therapy to Heart Failure Patients in the Outpatient Setting MOUNT LAUREL, N.J.–(BUSINESS WIRE)–Impulse Dynamics, developer of the implantable Optimizer Smart System for delivering Cardiac Contractility Modulation (also known as CCM™ therapy), announced that it has secured transitional […]
VANCOUVER, Nov. 4, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that the U.S. Food and Drug Administration (FDA) will hold a Cardiovascular and Renal Drugs Advisory Committee (CRDAC) meeting in connection with its review of the pending New Drug […]
ST. LOUIS and BARCELONA, Spain, Nov. 01, 2019 (GLOBE NEWSWIRE) — Stereotaxis (NYSE American: STXS) and ADAS 3D Medical SL today announced the first patients have been successfully treated with the integration of ADAS 3D’s advanced preoperative substrate mapping and Stereotaxis’ Robotic Magnetic Navigation technologies. ADAS 3D helps identify possible sources of dangerous irregular heartbeats and […]
TORONTO, Oct. 31, 2019 /PRNewswire/ – Baylis Medical announced today the first North American use of its EPstar™ Fixed Electrophysiology Catheters. The EPstar catheters make available the smallest diagnostic catheter in the North American electrophysiology market, allowing physicians to reach previously inaccessible areas of the heart for procedure mapping. The EPstar […]
BAUDETTE, Minn., Oct. 31, 2019 /PRNewswire/ — ANI Pharmaceuticals, Inc. (“ANI”) (Nasdaq: ANIP) today announced that its partner Pharmaceutics International Inc. (Pii) has received FDA approval of a Prior Approval Supplement for Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml). ANI plans to launch this currently unavailable drug in December, introducing this critical drug for the treatment of ventricular fibrillation and life-threatening […]
COPENHAGEN, Denmark, Oct. 31, 2019 /PRNewswire/ — CathVision ApS, a medical device company developing, manufacturing and selling cardiac electrophysiology products, has been awarded a competitive EU grant of 2.2M Euro for the clinical development of its software and clinical decision support platform. The EU grant is for an SME Instrument, Phase 2 under the Horizon2020 […]
